Tango Therapeutics grants 146,500-share non-qualified stock option
Tango Therapeutics said its Compensation Committee granted a non-qualified stock option to purchase 146,500 shares, effective September 1, 2026.
BOSTON, Sept.
03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc.
NASDAQ:TNGX (Tango Therapeutics or the Company) today announced that, effective September 1, 2026, the Compensation Committee of Tango Therapeutics' Board of Directors granted a non-qualified stock option to purchase 146,500 shares…